3.83 USD
+0.13 (+3.51%)
We assign a fundamental rating of 3 out of 10 to CCEL. CCEL was compared to 102 industry peers in the Health Care Providers & Services industry. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCEL has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CCEL has reported negative net income.
In the past year CCEL had a positive cash flow from operations.
Of the past 5 years CCEL 4 years were profitable.
CCEL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.75%, CCEL is in line with its industry, outperforming 46.08% of the companies in the same industry.
The Return On Invested Capital of CCEL (7.64%) is better than 71.57% of its industry peers.
CCEL had an Average Return On Invested Capital over the past 3 years of 7.61%. This is in line with the industry average of 9.61%.
The 3 year average ROIC (7.61%) for CCEL is below the current ROIC(7.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
CCEL's Profit Margin has declined in the last couple of years.
CCEL has a Operating Margin of 13.63%. This is amongst the best in the industry. CCEL outperforms 84.31% of its industry peers.
In the last couple of years the Operating Margin of CCEL has declined.
CCEL has a better Gross Margin (77.07%) than 91.18% of its industry peers.
CCEL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CCEL has been reduced compared to 1 year ago.
The number of shares outstanding for CCEL has been increased compared to 5 years ago.
Compared to 1 year ago, CCEL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.06, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CCEL (0.06) is worse than 79.41% of its industry peers.
The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.36, CCEL belongs to the best of the industry, outperforming 87.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.06 |
ROIC/WACC0.65
WACC11.82%
2.3 Liquidity
CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.63, CCEL is doing worse than 85.29% of the companies in the same industry.
CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL has a Quick ratio of 0.60. This is amonst the worse of the industry: CCEL underperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.34%, which is quite impressive.
Measured over the past years, CCEL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.04% on average per year.
Looking at the last year, CCEL shows a decrease in Revenue. The Revenue has decreased by -0.29% in the last year.
The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
The Earnings Per Share is expected to decrease by -202.32% on average over the next years. This is quite bad
Based on estimates for the next years, CCEL will show a decrease in Revenue. The Revenue will decrease by -3.22% on average per year.
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCEL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
CCEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CCEL is cheaper than 91.18% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 97.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.99 | ||
| EV/EBITDA | 6.02 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCEL's earnings are expected to decrease with -202.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 23.12%, CCEL is a good candidate for dividend investing.
The stock price of CCEL dropped by -23.71% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CCEL's Dividend Yield is rather good when compared to the industry average which is at 0.58. CCEL pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.12% |
5.2 History
CCEL has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2Y-202.32%
EPS Next 3YN/A
NYSEARCA:CCEL (12/22/2025, 12:31:54 PM)
3.83
+0.13 (+3.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.19%
Inst Owner Change-0.69%
Ins Owners41.98%
Ins Owner Change2.25%
Market Cap30.87M
Revenue(TTM)31.75M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (126.37%)
Short Float %0.19%
Short Ratio1.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.12% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.97 | ||
| P/FCF | 4.99 | ||
| P/OCF | 4.86 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.02 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY20.03%
OCF(TTM)0.79
OCFY20.59%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.06 |
F-Score7
WACC11.82%
ROIC/WACC0.65
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year43.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
What is the fundamental rating for CCEL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
Can you provide the valuation status for CRYO-CELL INTL INC?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
What is the financial health of CRYO-CELL INTL INC (CCEL) stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.